Kwiecien Catherine, Workman Alan D, Wilensky Jadyn, Lerner David K, Rathi Vinay K, Douglas Jennifer E, Kohanski Michael A, Kuan Edward C, Palmer James N, Adappa Nithin D
Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
Int Forum Allergy Rhinol. 2024 Nov;14(11):1739-1745. doi: 10.1002/alr.23412. Epub 2024 Jul 22.
Sinonasal malignancy surveillance paradigms are often based on Head and Neck National Comprehensive Cancer Network guidelines, which do not recommend standard surveillance imaging beyond 6 months without concerning symptomatology or physical examination findings.
This was a retrospective analysis of all patients who underwent resection of sinonasal malignancy at a tertiary care center over a 20-year period from 2000 to 2020, with an ensuing surveillance period demonstrating recurrence.
Fifty-two patients with sinonasal malignancy recurrence were included, with an average time to recurrence of 30.9 months and a follow-up period of over 60 months. Recurrence was diagnosed by routine imaging or endoscopy in asymptomatic patients in a majority (60%) of cases, while the remaining minority of diagnoses followed new symptomatology. Asymptomatic recurrence was associated with perineural spread of tumor at initial resection (p = 0.025), but not with age (p = 0.85) or stage at diagnosis (p = 0.68). Expectedly, positron emission tomography/computed tomography (CT) more often detected regional or distant recurrence, while structural imaging (CT/magnetic resonance imaging) demonstrated more frequent detection of recurrence in those with perineural spread of tumor (p = 0.01).
Our findings support high rates of asymptomatic recurrence in sinonasal malignancy, with the majority of recurrences diagnosed by routine endoscopy or imaging. Tailored and extended surveillance guidelines are necessary relative to those utilized for other head and neck mucosal cancers, and are especially appropriate when features such as perineural spread are present.
鼻窦恶性肿瘤的监测模式通常基于头颈国家综合癌症网络指南,该指南不建议在没有相关症状或体格检查结果的情况下,在6个月后进行标准监测成像。
这是一项对2000年至2020年期间在一家三级医疗中心接受鼻窦恶性肿瘤切除术的所有患者进行的回顾性分析,随后的监测期显示有复发情况。
纳入了52例鼻窦恶性肿瘤复发患者,平均复发时间为30.9个月,随访期超过60个月。在大多数(60%)病例中,无症状患者的复发是通过常规成像或内镜检查诊断出来的,而其余少数诊断是在出现新症状后做出的。无症状复发与初次切除时肿瘤的神经周围扩散有关(p = 0.025),但与年龄(p = 0.85)或诊断时的分期(p = 0.68)无关。不出所料,正电子发射断层扫描/计算机断层扫描(CT)更常检测到区域或远处复发,而结构成像(CT/磁共振成像)在肿瘤有神经周围扩散的患者中更频繁地检测到复发(p = 0.01)。
我们的研究结果支持鼻窦恶性肿瘤无症状复发率较高,大多数复发是通过常规内镜检查或成像诊断出来的。相对于用于其他头颈黏膜癌的监测指南,需要制定量身定制且延长的监测指南,当存在神经周围扩散等特征时尤其适用。